Patient‐reported outcomes following autologous stem cell transplant for patients with multiple myeloma-Reference-Cited by-同舟云学术

Patient‐reported outcomes following autologous stem cell transplant for patients with multiple myeloma

Published:2021-06-27 Issue:3 Volume:2 Page:488-492
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Biran Noa¹^ORCID,Zhai Wanting²,Jensen Roxanne E.³^ORCID,Mandelblatt Jeanne²^ORCID,Kumka Susan¹,Unawane Rashmi¹^ORCID,Graves Kristi D.²^ORCID,Vesole David H¹^ORCID,Siegel David S¹^ORCID,Potosky Arnold L.²^ORCID

Affiliation:

1. Hackensack Meridian Health John Theurer Cancer Center Hackensack New Jersey USA

2. Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center Georgetown University Medical Center Washington District of Columbia USA

3. Outcomes Research Branch, Healthcare Delivery Research Program National Cancer Institute Bethesda Maryland USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.231

Reference15 articles.

1. Myeloma – Cancer stat facts. SEER. May 12 2021.https://seer.cancer.gov/statfacts/html/mulmy.html

2. Towards the integration of patient-reported outcomes into the global clinical management of multiple myeloma

3. Estimation of an Instrument-Defined Minimally Important Difference in EQ-5D-5L Index Scores Based on Scoring Algorithms Derived Using the EQ-VT Version 2 Valuation Protocols

4. Symptom burden after autologous stem cell transplantation for multiple myeloma

5. Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patients;Etto LY;Clinics (Sao Paulo),2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EXABS-242-CT The Continued and Often Underappreciated Benefits of Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma (NDMM);Clinical Lymphoma Myeloma and Leukemia;2023-09

2. The Dynamics of Financial Toxicity in Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2023-04

3. The Dynamics of Financial Toxicity in Multiple Myeloma;2022-08-29

4. Chemotherapy-Related Differences in Cognitive Functioning and Their Biological Predictors in Patients with Multiple Myeloma;Brain Sciences;2021-09-01